US6103521A
(en)
*
|
1995-02-06 |
2000-08-15 |
Cell Genesys, Inc. |
Multispecific chimeric receptors
|
US5891680A
(en)
*
|
1995-02-08 |
1999-04-06 |
Whitehead Institute For Biomedical Research |
Bioactive fusion proteins comprising the p35 and p40 subunits of IL-12
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
WO1997014719A1
(en)
*
|
1995-10-16 |
1997-04-24 |
Unilever N.V. |
A bifunctional or bivalent antibody fragment analogue
|
WO1997023639A1
(fr)
*
|
1995-12-22 |
1997-07-03 |
Toray Industries, Inc. |
Procede de production de proteines fusionnees biologiquement actives
|
JP2000508892A
(ja)
*
|
1996-04-04 |
2000-07-18 |
ユニリーバー・ナームローゼ・ベンノートシャープ |
多価および多特異的抗原結合タンパク
|
US6136311A
(en)
|
1996-05-06 |
2000-10-24 |
Cornell Research Foundation, Inc. |
Treatment and diagnosis of cancer
|
US5922845A
(en)
|
1996-07-11 |
1999-07-13 |
Medarex, Inc. |
Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodies
|
US6242570B1
(en)
|
1997-07-10 |
2001-06-05 |
Beth Israel Deaconess Medical Center |
Production and use of recombinant protein multimers with increased biological activity
|
US6165476A
(en)
*
|
1997-07-10 |
2000-12-26 |
Beth Israel Deaconess Medical Center |
Fusion proteins with an immunoglobulin hinge region linker
|
US6187564B1
(en)
|
1997-07-10 |
2001-02-13 |
Beth Israel Deaconess Medical Center |
DNA encoding erythropoietin multimers having modified 5′ and 3′ sequences and its use to prepare EPO therapeutics
|
WO1999023221A2
(en)
*
|
1997-10-27 |
1999-05-14 |
Unilever Plc |
Multivalent antigen-binding proteins
|
DE19819846B4
(de)
*
|
1998-05-05 |
2016-11-24 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Multivalente Antikörper-Konstrukte
|
US6962702B2
(en)
|
1998-06-22 |
2005-11-08 |
Immunomedics Inc. |
Production and use of novel peptide-based agents for use with bi-specific antibodies
|
US7696325B2
(en)
|
1999-03-10 |
2010-04-13 |
Chugai Seiyaku Kabushiki Kaisha |
Polypeptide inducing apoptosis
|
NZ518320A
(en)
|
1999-10-18 |
2003-10-31 |
Prince Henrys Inst Med Res |
Immuno-interactive fragments of the alphaC subunit of inhibin
|
DE19957470A1
(de)
|
1999-11-24 |
2001-06-21 |
Actinodrug Pharmaceuticals Gmb |
Tetrahydropyrimidin-Dioxygenase-Gen sowie Verfahren zur enzymatischen in vivo und in vitro Produktion von hydroxylierten Tetrahydropyrimidinen
|
CN101289511A
(zh)
|
2000-04-11 |
2008-10-22 |
杰南技术公司 |
多价抗体及其应用
|
US6471968B1
(en)
|
2000-05-12 |
2002-10-29 |
Regents Of The University Of Michigan |
Multifunctional nanodevice platform
|
KR100388942B1
(ko)
*
|
2000-07-08 |
2003-06-25 |
한화석유화학 주식회사 |
인체의 피질 흉선 세포 및 백혈병 종양 세포 표면단백질을 인식하는 분절 항체
|
US20040010119A1
(en)
*
|
2001-02-12 |
2004-01-15 |
Xiaojia Guo |
Novel proteins and nucleic acids encoding same
|
DE60133479T2
(de)
|
2000-10-20 |
2009-04-16 |
Chugai Seiyaku K.K. |
Modifizierter tpo-agonisten antikörper
|
CN1308447C
(zh)
*
|
2000-10-20 |
2007-04-04 |
中外制药株式会社 |
低分子化的激动剂抗体
|
AU2002327164A1
(en)
*
|
2001-01-29 |
2002-12-09 |
Idec Pharmaceuticals Corporation |
Engineered tetravalent antibodies and methods of use
|
NZ527283A
(en)
*
|
2001-01-29 |
2006-03-31 |
Biogen Idec Inc |
Modified antibodies and methods of use
|
DE10156482A1
(de)
|
2001-11-12 |
2003-05-28 |
Gundram Jung |
Bispezifisches Antikörper-Molekül
|
CA2467836A1
(en)
*
|
2001-11-20 |
2003-09-04 |
Duke University |
Interfacial biomaterials
|
ATE512364T1
(de)
|
2002-08-07 |
2011-06-15 |
Ablynx Nv |
Modulation der blutplättchen-adhäsion basierend auf dem oberflächen-exponierten beta-switch loop des blutplättchen-glycoproteins ib-alpha
|
ATE414105T1
(de)
|
2002-10-11 |
2008-11-15 |
Chugai Pharmaceutical Co Ltd |
Zelltod-induzierender wirkstoff
|
US9701754B1
(en)
|
2002-10-23 |
2017-07-11 |
City Of Hope |
Covalent disulfide-linked diabodies and uses thereof
|
EP1587838B1
(de)
|
2003-01-10 |
2015-04-15 |
Ablynx N.V. |
Therapeutische polypeptide, deren homologe, deren fragmente und deren verwendung bei der modulierung der thrombozytenvermittelten aggregation
|
JP2004279086A
(ja)
|
2003-03-13 |
2004-10-07 |
Konica Minolta Holdings Inc |
放射線画像変換パネル及び放射線画像変換パネルの製造方法
|
EP1609803A4
(de)
*
|
2003-03-31 |
2006-05-24 |
Chugai Pharmaceutical Co Ltd |
Modifizierter antikörper gegen cd22 und anwendungen dafür
|
US7888134B2
(en)
*
|
2003-06-05 |
2011-02-15 |
Oakland University |
Immunosensors: scFv-linker design for surface immobilization
|
JP4794301B2
(ja)
*
|
2003-06-11 |
2011-10-19 |
中外製薬株式会社 |
抗体の製造方法
|
JP5091476B2
(ja)
*
|
2003-06-27 |
2012-12-05 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
均質な抗体溶液の生成のための疎水性相互作用クロマトグラフィーまたはヒンジ領域改変の使用
|
EP1660858A4
(de)
*
|
2003-07-21 |
2007-10-24 |
Amplified Proteomics Inc |
Multiplex-analytnachweis
|
US7696322B2
(en)
|
2003-07-28 |
2010-04-13 |
Catalent Pharma Solutions, Inc. |
Fusion antibodies
|
WO2005086612A2
(en)
*
|
2003-07-29 |
2005-09-22 |
Immunomedics, Inc. |
Fluorinated carbohydrate conjugates
|
AU2004297109A1
(en)
*
|
2003-12-12 |
2005-06-23 |
Chugai Seiyaku Kabushiki Kaisha |
Cell death inducing agent
|
WO2005056602A1
(ja)
*
|
2003-12-12 |
2005-06-23 |
Chugai Seiyaku Kabushiki Kaisha |
アゴニスト活性を有する改変抗体のスクリーニング方法
|
TW200530269A
(en)
|
2003-12-12 |
2005-09-16 |
Chugai Pharmaceutical Co Ltd |
Anti-Mpl antibodies
|
US20050282233A1
(en)
*
|
2004-03-05 |
2005-12-22 |
Ludwig Institute For Cancer Research |
Multivalent antibody materials and methods for VEGF/PDGF family of growth factors
|
US20080274110A1
(en)
*
|
2004-04-09 |
2008-11-06 |
Shuji Ozaki |
Cell Death-Inducing Agents
|
US8470315B2
(en)
|
2004-04-13 |
2013-06-25 |
Quintessence Biosciences, Inc. |
Non-natural ribonuclease conjugates as cytotoxic agents
|
EP2255832A3
(de)
*
|
2004-06-16 |
2011-02-09 |
Affinergy, Inc. |
Grenzflächenbiomaterialien zur Förderung der Anhaftung von Zielanalyten
|
JP2008510829A
(ja)
*
|
2004-08-25 |
2008-04-10 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
デンドリマーに基づく組成物およびそれらの使用法
|
WO2006074399A2
(en)
*
|
2005-01-05 |
2006-07-13 |
Biogen Idec Ma Inc. |
Multispecific binding molecules comprising connecting peptides
|
WO2006074947A2
(en)
|
2005-01-14 |
2006-07-20 |
Ablynx N.V. |
METHODS AND ASSAYS FOR DISTINGUISHING BETWEEN DIFFERENT FORMS OF DISEASES AND DISORDERS CHARACTERIZED BY THROMBOCYTOPENIA AND/OR BY SPONTANEOUS INTERACTION BETWEEN VON WILLEBRAND FACTOR (vWF) AND PLATELETS
|
US9493569B2
(en)
|
2005-03-31 |
2016-11-15 |
Chugai Seiyaku Kabushiki Kaisha |
Structural isomers of sc(Fv)2
|
JP5620626B2
(ja)
|
2005-03-31 |
2014-11-05 |
中外製薬株式会社 |
会合制御によるポリペプチド製造方法
|
EP1927367A4
(de)
*
|
2005-05-18 |
2009-08-12 |
Univ Tokushima |
Neues pharmazeutisches mittel mit anti-hla-antikörper
|
KR101414438B1
(ko)
|
2005-05-20 |
2014-07-10 |
아블린쓰 엔.브이. |
폰 빌레브란트 인자에 대한 단일 도메인 vhh 항체
|
KR101360671B1
(ko)
|
2005-06-10 |
2014-02-07 |
추가이 세이야쿠 가부시키가이샤 |
sc(Fv)2를 함유하는 의약조성물
|
JP5224580B2
(ja)
*
|
2005-06-10 |
2013-07-03 |
中外製薬株式会社 |
sc(Fv)2部位特異的変異体
|
AU2006256041B2
(en)
|
2005-06-10 |
2012-03-29 |
Chugai Seiyaku Kabushiki Kaisha |
Stabilizer for protein preparation comprising meglumine and use thereof
|
US20070041934A1
(en)
*
|
2005-08-12 |
2007-02-22 |
Regents Of The University Of Michigan |
Dendrimer based compositions and methods of using the same
|
ATE509033T1
(de)
*
|
2006-03-20 |
2011-05-15 |
Univ California |
Manipulierte anti-prostatastammzellenantigen (psca)-antikörper für krebs-targeting
|
US9670269B2
(en)
|
2006-03-31 |
2017-06-06 |
Chugai Seiyaku Kabushiki Kaisha |
Methods of modifying antibodies for purification of bispecific antibodies
|
WO2007145227A1
(ja)
*
|
2006-06-14 |
2007-12-21 |
Chugai Seiyaku Kabushiki Kaisha |
造血幹細胞増加促進剤
|
US8840882B2
(en)
*
|
2006-06-23 |
2014-09-23 |
Quintessence Biosciences, Inc. |
Modified ribonucleases
|
AR061986A1
(es)
*
|
2006-07-13 |
2008-08-10 |
Chugai Pharmaceutical Co Ltd |
Agentes inductores de muerte celular
|
US8298801B2
(en)
*
|
2006-07-17 |
2012-10-30 |
Quintessence Biosciences, Inc. |
Methods and compositions for the treatment of cancer
|
CL2008000719A1
(es)
*
|
2007-03-12 |
2008-09-05 |
Univ Tokushima Chugai Seiyaku |
Agente terapeutico para cancer resistente a agentes quimioterapeuticos que comprende un anticuerpo que reconoce hla de clase i como ingrediente activo; composicion farmaceutica que comprende dicho anticuerpo; y metodo para tratar cancer resistente a
|
AU2008275501A1
(en)
*
|
2007-04-19 |
2009-01-15 |
The Regents Of The University Of Michigan |
Dendrimer based compositions and methods of using the same
|
EP2156186A4
(de)
*
|
2007-05-03 |
2010-11-03 |
Tethys Bioscience Inc |
Bindungsreagenzien mit kleinen epitopbindenden molekülen
|
EP2162554A4
(de)
|
2007-05-31 |
2010-07-28 |
Univ Queensland |
Diagnostische marker für spondylitis ankylosans und verwendungen dafür
|
WO2009026540A1
(en)
*
|
2007-08-22 |
2009-02-26 |
Colorado School Of Mines |
Lanthanide nanoparticle conjugates and uses thereof
|
US8940298B2
(en)
*
|
2007-09-04 |
2015-01-27 |
The Regents Of The University Of California |
High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection
|
EP2740490A1
(de)
*
|
2007-10-03 |
2014-06-11 |
Cornell University |
Behandlung von proliferativen Erkrankungen mit PSMA-Antikörpern
|
EP2205271B1
(de)
*
|
2007-10-08 |
2014-05-21 |
Quintessence Biosciences, Inc. |
Zusammensetzungen und verfahren für therapien auf ribonukleasebasis
|
US8075755B2
(en)
*
|
2007-12-13 |
2011-12-13 |
Bio-Rad Laboratories, Inc. |
Polymeric sorbent sheets as ion reservoirs for electroblotting
|
US8414893B2
(en)
|
2007-12-21 |
2013-04-09 |
Amgen Inc. |
Anti-amyloid antibodies and uses thereof
|
BRPI0907640A2
(pt)
|
2008-01-25 |
2015-11-03 |
Univ Aarhus |
inibição exosítio-seletiva da atividade de papp-a contra igfbp-4
|
AU2009206306B2
(en)
|
2008-01-25 |
2013-06-06 |
Amgen Inc. |
Ferroportin antibodies and methods of use
|
US8252834B2
(en)
|
2008-03-12 |
2012-08-28 |
The Regents Of The University Of Michigan |
Dendrimer conjugates
|
WO2009139822A1
(en)
|
2008-05-01 |
2009-11-19 |
Amgen Inc. |
Anti-hepcidin antibodies and methods of use
|
EP2307042B1
(de)
|
2008-06-25 |
2014-03-26 |
H. Lundbeck A/S |
Modulierung des trpv : vps10p domänen-rezeptorsystems zur behandlung von schmerzen
|
US20100069616A1
(en)
*
|
2008-08-06 |
2010-03-18 |
The Regents Of The University Of California |
Engineered antibody-nanoparticle conjugates
|
US8968705B2
(en)
|
2008-08-22 |
2015-03-03 |
Colorado School Of Mines |
Gold/lanthanide nanoparticle conjugates and uses thereof
|
US8790642B2
(en)
|
2008-08-29 |
2014-07-29 |
Genentech, Inc. |
Cross-reactive and bispecific anti-IL-17A/F antibodies
|
US8889635B2
(en)
|
2008-09-30 |
2014-11-18 |
The Regents Of The University Of Michigan |
Dendrimer conjugates
|
EP2334695B1
(de)
|
2008-10-01 |
2015-12-23 |
Quintessence Biosciences, Inc. |
Therapeutische ribonukleasen
|
EP2352490A4
(de)
|
2008-10-09 |
2013-11-20 |
Univ Northeastern |
Selbstanordnende polymere multifunktionsnanosysteme
|
WO2010054321A2
(en)
|
2008-11-07 |
2010-05-14 |
The Regents Of The University Of Michigan |
Methods of treating autoimmune disorders and/or inflammatory disorders
|
EP2379593A2
(de)
|
2008-12-19 |
2011-10-26 |
H. Lundbeck A/S |
Modulation der vps-10-domänenrezeptorfamilie zur behandlung von geistes- und verhaltensstörungen
|
EP3495000A1
(de)
*
|
2009-02-17 |
2019-06-12 |
Cornell Research Foundation, Inc. |
Verfahren und kits zur diagnose von krebs und vorhersage des therapeutischen werts
|
US20120121591A1
(en)
|
2009-03-20 |
2012-05-17 |
Amgen Inc. |
SELECTIVE AND POTENT PEPTIDE INHIBITORS OF Kv1.3
|
WO2010112034A2
(en)
|
2009-04-02 |
2010-10-07 |
Aarhus Universitet |
Compositions and methods for treatment and diagnosis of synucleinopathies
|
US9493578B2
(en)
|
2009-09-02 |
2016-11-15 |
Xencor, Inc. |
Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens
|
WO2011059609A2
(en)
|
2009-10-13 |
2011-05-19 |
The Regents Of The University Of Michigan |
Dendrimer compositions and methods of synthesis
|
US8912323B2
(en)
|
2009-10-30 |
2014-12-16 |
The Regents Of The University Of Michigan |
Multifunctional small molecules
|
WO2011054359A2
(en)
|
2009-11-06 |
2011-05-12 |
University Of Copenhagen |
Method for early detection of cancer
|
CA2781532A1
(en)
|
2009-11-20 |
2011-05-26 |
Amgen Inc. |
Anti-orai1 antigen binding protein that binds the second extracellular loop of orai1
|
MX354143B
(es)
|
2009-12-02 |
2018-02-14 |
Imaginab Inc |
Minicuerpos j591 y diacuerpos-cys para apuntar con especificidad de objetivo a un antígeno de membrana específico para próstata de humano (psma) y métodos para su uso.
|
US8715476B2
(en)
|
2009-12-11 |
2014-05-06 |
Bio-Rad Laboratories, Inc. |
Instrument for independent electrotransfer in multiple cassettes
|
US20110201076A1
(en)
|
2010-01-22 |
2011-08-18 |
Colorado School Of Mines |
Harvesting micro algae
|
ES2606627T3
(es)
|
2010-05-28 |
2017-03-24 |
Inserm - Institut National De La Santé Et De La Recherche Médicale |
Anticuerpos específicos anti-CD160 para el tratamiento de trastornos oculares basados en la neoangiogénesis
|
US8637641B2
(en)
|
2010-07-29 |
2014-01-28 |
Xencor, Inc. |
Antibodies with modified isoelectric points
|
US8993727B2
(en)
|
2010-09-22 |
2015-03-31 |
Amgen Inc. |
Carrier immunoglobulins and uses thereof
|
US10851178B2
(en)
|
2011-10-10 |
2020-12-01 |
Xencor, Inc. |
Heterodimeric human IgG1 polypeptides with isoelectric point modifications
|
WO2013085718A1
(en)
|
2011-12-08 |
2013-06-13 |
The Regents Of The University Of Michigan |
Multifunctional small molecules
|
CA2878587A1
(en)
*
|
2012-07-23 |
2014-01-30 |
Zymeworks Inc. |
Immunoglobulin constructs comprising selective pairing of the light and heavy chains
|
AU2014205086B2
(en)
|
2013-01-14 |
2019-04-18 |
Xencor, Inc. |
Novel heterodimeric proteins
|
US9605084B2
(en)
|
2013-03-15 |
2017-03-28 |
Xencor, Inc. |
Heterodimeric proteins
|
US10131710B2
(en)
|
2013-01-14 |
2018-11-20 |
Xencor, Inc. |
Optimized antibody variable regions
|
US10968276B2
(en)
|
2013-03-12 |
2021-04-06 |
Xencor, Inc. |
Optimized anti-CD3 variable regions
|
US9701759B2
(en)
|
2013-01-14 |
2017-07-11 |
Xencor, Inc. |
Heterodimeric proteins
|
US10487155B2
(en)
|
2013-01-14 |
2019-11-26 |
Xencor, Inc. |
Heterodimeric proteins
|
US11053316B2
(en)
|
2013-01-14 |
2021-07-06 |
Xencor, Inc. |
Optimized antibody variable regions
|
AU2014207549B2
(en)
|
2013-01-15 |
2018-12-06 |
Xencor, Inc. |
Rapid clearance of antigen complexes using novel antibodies
|
US10858417B2
(en)
|
2013-03-15 |
2020-12-08 |
Xencor, Inc. |
Heterodimeric proteins
|
US10106624B2
(en)
|
2013-03-15 |
2018-10-23 |
Xencor, Inc. |
Heterodimeric proteins
|
US10519242B2
(en)
|
2013-03-15 |
2019-12-31 |
Xencor, Inc. |
Targeting regulatory T cells with heterodimeric proteins
|
US10544187B2
(en)
|
2013-03-15 |
2020-01-28 |
Xencor, Inc. |
Targeting regulatory T cells with heterodimeric proteins
|
CN105555756B
(zh)
|
2013-06-28 |
2018-12-07 |
奥克兰联合服务有限公司 |
氨基酸缀合物和肽缀合物及缀合方法
|
US20160208016A1
(en)
|
2013-08-29 |
2016-07-21 |
University Of Copenhagen |
Anti-ADAM12 antibodies for the treatment of cancer
|
RU2758952C1
(ru)
|
2013-09-27 |
2021-11-03 |
Чугаи Сейяку Кабусики Кайся |
Способ получения полипептидного гетеромультимера
|
AP2016009475A0
(en)
|
2014-03-28 |
2016-09-30 |
Xencor Inc |
Bispecific antibodies that bind to cd38 and cd3
|
EP3164417A1
(de)
|
2014-07-01 |
2017-05-10 |
Pfizer Inc. |
Bispezifische heterodimere diabodies und verwendungen davon
|
MX2017006918A
(es)
|
2014-11-26 |
2018-01-25 |
Xencor Inc |
Anticuerpos heterodimericos que se unen a cd3 y cd38.
|
PE20171324A1
(es)
|
2014-11-26 |
2017-09-11 |
Xencor Inc |
Anticuerpos heterodimericos que se unen a cd3 y a antigenos tumorales
|
US10259887B2
(en)
|
2014-11-26 |
2019-04-16 |
Xencor, Inc. |
Heterodimeric antibodies that bind CD3 and tumor antigens
|
WO2016105450A2
(en)
|
2014-12-22 |
2016-06-30 |
Xencor, Inc. |
Trispecific antibodies
|
BR112017013574A2
(pt)
|
2014-12-23 |
2018-03-06 |
Verdon Daniel |
conjugados de aminoácido e peptídeo e usos dos mesmos
|
WO2016141387A1
(en)
|
2015-03-05 |
2016-09-09 |
Xencor, Inc. |
Modulation of t cells with bispecific antibodies and fc fusions
|
EP3271402B1
(de)
|
2015-03-16 |
2021-04-28 |
Aarhus Universitet |
Antikörper gegen ein extrazelluläres region nbcn1
|
WO2016150444A1
(en)
|
2015-03-20 |
2016-09-29 |
Aarhus Universitet |
Inhibitors of pcsk9 for treatment of lipoprotein metabolism disorders
|
KR20180050321A
(ko)
|
2015-08-07 |
2018-05-14 |
이미지냅 인코포레이티드 |
분자를 표적화하기 위한 항원 결합 구조체
|
EP3387013B1
(de)
|
2015-12-07 |
2022-06-08 |
Xencor, Inc. |
Cd3 und psma bindende heterodimere antikörper
|
KR20180091918A
(ko)
|
2015-12-28 |
2018-08-16 |
추가이 세이야쿠 가부시키가이샤 |
Fc 영역 함유 폴리펩타이드의 정제를 효율화하기 위한 방법
|
JP7161404B2
(ja)
|
2016-02-26 |
2022-10-26 |
オークランド ユニサービシーズ リミティド |
アミノ酸及びペプチド接合体及び接合方法
|
RU2767357C2
(ru)
|
2016-06-14 |
2022-03-17 |
Ксенкор, Инк. |
Биспецифические антитела-ингибиторы контрольных точек
|
CA3029328A1
(en)
|
2016-06-28 |
2018-01-04 |
Xencor, Inc. |
Heterodimeric antibodies that bind somatostatin receptor 2
|
US11319379B2
(en)
*
|
2016-08-04 |
2022-05-03 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Affinity maturated TAG72 specific single chain antibodies
|
US10793632B2
(en)
|
2016-08-30 |
2020-10-06 |
Xencor, Inc. |
Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors
|
JP7046381B2
(ja)
|
2016-09-20 |
2022-04-04 |
オーフス ウニベルシテット |
リポタンパク質代謝障害の治療のための化合物
|
WO2018071919A1
(en)
|
2016-10-14 |
2018-04-19 |
Xencor, Inc. |
IL15/IL15Rα HETERODIMERIC FC-FUSION PROTEINS
|
WO2018141029A1
(en)
|
2017-02-06 |
2018-08-09 |
Meat & Livestock Australia Limited |
Immunostimulating compositions and uses therefore
|
WO2018147960A1
(en)
|
2017-02-08 |
2018-08-16 |
Imaginab, Inc. |
Extension sequences for diabodies
|
CN111132733A
(zh)
|
2017-06-30 |
2020-05-08 |
Xencor股份有限公司 |
含有IL-15/IL-15Rα和抗原结合结构域的靶向异源二聚体Fc融合蛋白
|
CN112272563A
(zh)
|
2017-11-08 |
2021-01-26 |
Xencor股份有限公司 |
使用新颖抗pd-1序列的双特异性和单特异性抗体
|
US10981992B2
(en)
|
2017-11-08 |
2021-04-20 |
Xencor, Inc. |
Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors
|
KR20200100098A
(ko)
|
2017-12-19 |
2020-08-25 |
젠코어 인코포레이티드 |
조작된 il-2 fc 융합 단백질
|
WO2019195623A2
(en)
|
2018-04-04 |
2019-10-10 |
Xencor, Inc. |
Heterodimeric antibodies that bind fibroblast activation protein
|
JP2021521784A
(ja)
|
2018-04-18 |
2021-08-30 |
ゼンコア インコーポレイテッド |
IL−15/IL−15RaFc融合タンパク質とPD−1抗原結合ドメインを含むPD−1標的化ヘテロダイマー融合タンパク質およびそれらの使用
|
KR20210003814A
(ko)
|
2018-04-18 |
2021-01-12 |
젠코어 인코포레이티드 |
IL-15/IL-15Rα Fc-융합 단백질 및 TIM-3 항원 결합 도메인을 함유하는 TIM-3 표적화 이종이량체 융합 단백질
|
WO2020072821A2
(en)
|
2018-10-03 |
2020-04-09 |
Xencor, Inc. |
Il-12 heterodimeric fc-fusion proteins
|
MX2021010390A
(es)
|
2019-03-01 |
2021-11-17 |
Xencor Inc |
Anticuerpos heterodimericos que se unen a enpp3 y cd3.
|
US11919956B2
(en)
|
2020-05-14 |
2024-03-05 |
Xencor, Inc. |
Heterodimeric antibodies that bind prostate specific membrane antigen (PSMA) and CD3
|
IL305736A
(en)
|
2021-03-09 |
2023-11-01 |
Xencor Inc |
Heterodimeric antibodies that bind CD3 and CLDN6
|
EP4305065A1
(de)
|
2021-03-10 |
2024-01-17 |
Xencor, Inc. |
Cd3 und gpc3 bindende heterodimere antikörper
|
WO2023186131A1
(zh)
*
|
2022-04-02 |
2023-10-05 |
合肥星眸生物科技有限公司 |
一种编码抗vegf-a和ang-2双特异性抗体的aav载体
|